abstract |
The present invention relates to improved methods for treating anemia. Compounds which stabilise HIF-alpha useful for treating anemia, wherein the anemia treatment is associated with a lower risk of thrombosis or hypertension compared to that observed with rhEPO therapy, are provided. |